Adipose-derived stem cells are a subtype of mesenchymal stem cell that offers the important advantage of being easily obtained (in an autologous manner) from low invasive procedures, rendering a high number of multipotent stem cells with the potential to differentiate into several cellular lineages, to show immunomodulatory properties, and to promote tissue regeneration by a paracrine action through the secretion of extracellular vesicles containing trophic factors. This secretome is currently being investigated as a potential source for a cell-free based regenerative therapy for human tissues, which would significantly reduce the involved costs, risks and law regulations, allowing for a broader application in real clinical practice. In the current article, we will review the existing preclinical and human clinical evidence regarding the use of such adipose-derived mesenchymal stem cells for the regeneration of the three main layers of the human cornea: the epithelium (derived from the surface ectoderm), the stroma (derived from the neural crest mesenchyme), and the endothelium (derived from the neural crest cells).
This study aimed to evaluate the effect of small-incision lenticule extraction (SMILE/KLEx) on axial length (AXL) progression and refractive stability in young adults with moderate to high myopia and documented preoperative progression. This prospective study included 100 eyes of 50 patients aged 18-21 years who underwent SMILE/KLEx. AXL, spherical equivalent (SE), corneal curvature, and central corneal thickness (CCT) were measured 1 year pre-baseline (T - 1), at baseline (T0), and postoperatively at 6 months (T1), 1 year (T2), and 3 years (T3). Agreement between estimated and observed AXL elongation was assessed using Bland-Altman analysis, and generalized estimating equation (GEE) models were used to account for inter-eye correlations and evaluate changes from baseline. Median AXL showed limited progression throughout follow-up (26.05 mm at T0, 26.14 mm at T2, 26.26 mm at T3), SE improved from - 6.00 D to - 0.25 D, and corneal parameters showed early postoperative changes followed by long-term stability. Visual outcomes were satisfactory, with no significant intraoperative or postoperative complications. In conclusion, SMILE/KLEx provided effective refractive correction in this cohort of young adults with documented preoperative myopic progression. Over 3 years, axial length showed no statistically significant progression at the group level, although individual-level elongation was heterogeneous and remained within the expected physiological range for young adults.